新型高解析度超音波改善攝護腺癌診斷
New high-resolution ultrasound improves prostate cancer diagnosis
攝護腺癌診斷領域正出現一項重大突破，即高解析度微超音波(microUS)技術。
A significant breakthrough in prostate cancer diagnostics is emerging through high-resolution micro-ultrasound (microUS) technology.
此系統以 29 MHz 的頻率運作，幾乎是傳統超音波的三倍，它提供了顯微等級的細節，讓臨床醫師能觀察到過去難以發現的細微結構差異。
Operating at 29 MHz—nearly triple the frequency of conventional ultrasound—this system provides microscopic detail, allowing clinicians to visualize subtle structural variations previously invisible.
轉向這項技術能提供「一站式」的診斷流程，患者可在同一次門診中完成影像檢查與切片。
The shift toward this technology offers a "one-stop" diagnostic workflow, where patients can undergo imaging and biopsy during a single office visit.
除了效率之外，超音波掃描儀相較於昂貴的 MRI 設備成本更低且取得更容易，這意味著高品質的診斷護理在醫療資源短缺的地區將更易於推及。
Beyond efficiency, the lower cost and increased availability of ultrasound scanners compared to expensive MRI machines mean that high-quality diagnostic care could become more accessible, particularly in underserved regions.
此外，微超音波減少了對 MRI 的依賴，因為 MRI 常因患者體內裝設特定植入物而無法進行，且在切片時可能會受到對位誤差的影響。
Additionally, microUS reduces reliance on MRI, which is often inaccessible to patients with specific implants and can struggle with alignment errors during biopsies.
透過將高保真度視覺引導與 PRI-MUS 等標準分級協議相結合，此項技術正在提升診斷的精確度。
By combining high-fidelity visual guidance with standardized grading protocols like PRI-MUS, this technology is improving diagnostic precision.
隨著人工智慧與局部治療應用的發展，微超音波勢必將變革以患者為中心的護理模式，提供更快、更準確的診斷結果，同時減輕傳統診斷過程所引發的焦慮。
As AI and focal therapy applications advance, micro-ultrasound is poised to transform patient-centered care, providing faster, more accurate results while minimizing the anxiety associated with traditional diagnostic paths.
